Castle Biosciences shareholders approve officer exculpation charter amendment; re-elect directors

CASTLE BIOSCIENCES INC

Stockholders approved amendment to certificate of incorporation to limit officer liability per Delaware law, effective May 22, 2025.
Re-elected Class III directors Kimberlee S. Caple, G. Bradley Cole, and Derek J. Maetzold to terms expiring 2028.
Ratified KPMG as independent auditor for FY2025 with 23.7M votes for, 20.8K against.
Approved advisory say-on-pay proposal with 20.0M for, 1.3M against, 43K abstain.
All proposals passed with overwhelming support; broker non-votes noted for director election and say-on-pay.

item 3.03item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.